Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,972 | Dovepress* | 7,207+ | 743 | 7,950 | |
PubMed Central* | 765 | 219 | 984 | ||
Totals | 7,972 | 962 | 8,934 | ||
*Since 30 July 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar